Sigma-Aldrich (Shanghai) Trading: difference between revisions
Diff·revision 8 → 9·07:19, 17 Jun 2025
Difference between revision 8 and revision 9 of Sigma-Aldrich (Shanghai) Trading. 5 lines changed; the page grew by 673 bytes.
| Revision 8 — 06:57, 6 Jun 2025 StubSorterBot (talk) bot: sort category members 6,965 bytes +192 | Revision 9 — 07:19, 17 Jun 2025 ReportReaderRilla (talk) expand §Independent testing record 7,638 bytes +673 | ||
|---|---|---|---|
| 36 | Two determinations are described as absent. Counter-ion identity is not quantified on the certificate as issued, and water content is released only on request. Without both, a purity percentage cannot be read as a statement about delivered [[Peptide content|peptide mass]], and that constrains what the documentation supports.{{r|reports,usp1503}} | 36 | Two determinations are described as absent. Counter-ion identity is not quantified on the certificate as issued, and water content is released only on request. Without both, a purity percentage cannot be read as a statement about delivered [[Peptide content|peptide mass]], and that constrains what the documentation supports.{{r|reports,usp1503}} |
| 37 | 37 | ||
| + | 38 | == Product range == | |
| + | 39 | The organisation's own listing describes upwards of 500 research lines spanning peptides, selective androgen receptor modulators, injectable oils and bulk raw material.{{r|selfpub}} Catalogue size is self-reported and is not verified here; a listing is an offer to supply rather than evidence of stock, capability, or of anything having been made. | |
| + | 40 | ||
| + | 41 | Submitted reports cover the incretin analogues most heavily, with a smaller set on repair peptides and a handful on bulk raw material. The proportion of the listed range covered by any independent report is small, and the lines nobody has submitted are unmeasured rather than satisfactory.{{r|reports}} | |
| + | 42 | ||
| 38 | == References == | 43 | == References == |
| 39 | {{reflist}} | 44 | {{reflist}} |